Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rossella Talotta

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Israel Medical Association Journal : IMAJ|May 28, 2016
Infections and Biological Therapy in Patients with Rheumatic DiseasesFabiola Atzeni, Alberto Batticciotto, Ignazio F Masala, et al.
Expert Review of Clinical Pharmacology|September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Journal of Personalized Medicine|April 28, 2023
Management of Patients Affected by Giant Cell Arteritis during the COVID-19 Pandemic: Telemedicine Protocol TELEMACOVSimone Parisi, Maria Chiara Ditto, Rossella Talotta, et al.
Journal of Medical Case Reports|June 4, 2018
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case seriesRossella Talotta, Fabiola Atzeni, Alberto Batticciotto, et al.
Journal of Clinical Immunology|August 15, 2015
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical ResponseRossella Talotta, Angela Berzi, Fabiola Atzeni, et al.
Expert Review of Clinical Pharmacology|January 23, 2016
Novel pharmaceutical options for treating fibromyalgiaMaria Chiara Gerardi, Alberto Batticciotto, Rossella Talotta, et al.
The Israel Medical Association Journal : IMAJ|June 22, 2021
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life DataFabiola Atzeni, Elisabetta Gerratana, Sara Bongiovanni, et al.
Best Practice & Research. Clinical Rheumatology|June 9, 2019
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agentsFabiola Atzeni, Rossella Talotta, Ignazio Francesco Masala, et al.
Immunotherapy|April 29, 2015
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?Fabiola Atzeni, Luigi Gianturco, Rossella Talotta, et al.
Clinical and Experimental Rheumatology|March 19, 2015
Algo-dysfunctional syndromes: a critical digest of the recent literatureRossella Talotta, Fabiola Atzeni, Laura Bazzichi, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Israel Medical Association Journal : IMAJ|May 28, 2016
Infections and Biological Therapy in Patients with Rheumatic DiseasesFabiola Atzeni, Alberto Batticciotto, Ignazio F Masala, et al.
Expert Review of Clinical Pharmacology|September 17, 2016
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?Fabiola Atzeni, Maurizio Benucci, Rossella Talotta, et al.
Journal of Personalized Medicine|April 28, 2023
Management of Patients Affected by Giant Cell Arteritis during the COVID-19 Pandemic: Telemedicine Protocol TELEMACOVSimone Parisi, Maria Chiara Ditto, Rossella Talotta, et al.
Journal of Medical Case Reports|June 4, 2018
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case seriesRossella Talotta, Fabiola Atzeni, Alberto Batticciotto, et al.
Journal of Clinical Immunology|August 15, 2015
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical ResponseRossella Talotta, Angela Berzi, Fabiola Atzeni, et al.
Expert Review of Clinical Pharmacology|January 23, 2016
Novel pharmaceutical options for treating fibromyalgiaMaria Chiara Gerardi, Alberto Batticciotto, Rossella Talotta, et al.
The Israel Medical Association Journal : IMAJ|June 22, 2021
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life DataFabiola Atzeni, Elisabetta Gerratana, Sara Bongiovanni, et al.
Best Practice & Research. Clinical Rheumatology|June 9, 2019
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agentsFabiola Atzeni, Rossella Talotta, Ignazio Francesco Masala, et al.
Immunotherapy|April 29, 2015
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?Fabiola Atzeni, Luigi Gianturco, Rossella Talotta, et al.
Clinical and Experimental Rheumatology|March 19, 2015
Algo-dysfunctional syndromes: a critical digest of the recent literatureRossella Talotta, Fabiola Atzeni, Laura Bazzichi, et al.
Pageof 6